Clovis shares rocket after FDA decision

Clovis Oncology shares shot up more than 26 percent Tuesday after the U.S. Food and Drug Administration accepted the company's new drug application.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.